Regeneron (NASDAQ: REGN) reported Q3 EPS of $11.14, $1.32 better than the analyst estimate of $9.82. Revenue for the quarter came in at $2.94 billion versus the consensus estimate of $2.94 billion.

For earnings history and earnings-related data on Regeneron (REGN) click here.